These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31446183)

  • 21. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysplasia Detected in Patients With Serrated Epithelial Change Is Frequently Associated With an Invisible or Flat Endoscopic Appearance, Nonconventional Dysplastic Features, and Advanced Neoplasia.
    Bahceci D; Alpert L; Storozuk T; Liao X; Yozu M; Westerhoff M; Kővári BP; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Oct; 48(10):1326-1334. PubMed ID: 38907614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
    Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps.
    de Jong ME; Gillis VELM; Derikx LAAP; Hoentjen F
    Inflamm Bowel Dis; 2020 Aug; 26(9):1383-1389. PubMed ID: 31677385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
    Cremer A; Demetter P; De Vos M; Rahier JF; Baert F; Moreels T; Macken E; Louis E; Ferdinande L; Fervaille C; Dedeurwaerdere F; Bletard N; Driessen A; De Hertogh G; Vermeire S; Franchimont D;
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1528-1536.e5. PubMed ID: 31202983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
    Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
    Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
    Wijnands AM; de Jong ME; Lutgens MWMD; Hoentjen F; Elias SG; Oldenburg B;
    Gastroenterology; 2021 Apr; 160(5):1584-1598. PubMed ID: 33385426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop.
    Axelrad JE; Cross RK
    Am J Gastroenterol; 2023 Mar; 118(3):429-431. PubMed ID: 36584365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M
    Dig Dis; 2010; 28(4-5):619-624. PubMed ID: 21088413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Moussata D; Allez M; Cazals-Hatem D; Treton X; Laharie D; Reimund JM; Bertheau P; Bourreille A; Lavergne-Slove A; Brixi H; Branche J; Gornet JM; Stefanescu C; Moreau J; Marteau P; Pelletier AL; Carbonnel F; Seksik P; Simon M; Fléjou JF; Colombel JF; Charlois AL; Roblin X; Nancey S; Bouhnik Y; Berger F; Flourié B;
    Gut; 2018 Apr; 67(4):616-624. PubMed ID: 28115492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.
    Ullman T; Croog V; Harpaz N; Sachar D; Itzkowitz S
    Gastroenterology; 2003 Nov; 125(5):1311-9. PubMed ID: 14598247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis.
    Imam MH; Eaton JE; Puckett JS; Loftus EV; Mathis KL; Gossard AA; Talwalkar JA; Lindor KD
    J Crohns Colitis; 2014 Oct; 8(10):1294-9. PubMed ID: 24768559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low Incidence of Dysplasia and Colorectal Cancer Observed among Inflammatory Bowel Disease Patients with Prolonged Colonic Diversion.
    Bettner W; Rizzo A; Brant S; Dudley-Brown S; Efron J; Fang S; Gearhart S; Marohn M; Parian A; Kherad Pezhouh M; Melia J; Safar B; Truta B; Wick E; Lazarev M
    Inflamm Bowel Dis; 2018 Apr; 24(5):1092-1098. PubMed ID: 29688465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
    Itzkowitz SH; Harpaz N
    Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasia.
    Horvath B; Liu G; Wu X; Lai KK; Shen B; Liu X
    Gastroenterol Rep (Oxf); 2015 Nov; 3(4):344-9. PubMed ID: 26063242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship.
    Wijnands AM; Elias SG; Dekker E; Fidder HH; Hoentjen F; Ten Hove JR; Maljaars PWJ; van der Meulen-de Jong AE; Mooiweer E; Ouwehand RJ; Penning de Vries BBL; Ponsioen CY; van Schaik FDM; Oldenburg B;
    United European Gastroenterol J; 2023 Sep; 11(7):612-620. PubMed ID: 37505117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer and high grade dysplasia complicating ulcerative colitis in Italy. A retrospective co-operative IG-IBD study.
    Riegler G; Bossa F; Caserta L; Pera A; Tonelli F; Sturniolo GC; Oliva L; Contessini Avesani E; Poggioli G;
    Dig Liver Dis; 2003 Sep; 35(9):628-34. PubMed ID: 14563184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines.
    Zisman TL; Bronner MP; Rulyak S; Kowdley KV; Saunders M; Lee SD; Ko C; Kimmey MB; Stevens A; Maurer J; Brentnall TA
    Inflamm Bowel Dis; 2012 Dec; 18(12):2240-6. PubMed ID: 22508402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.